Samsrita Labs Reports No Preferential Issue Fund Deviation

Disclosure Context

Samsrita Labs Limited submitted a regulatory filing to BSE Limited and Metropolitan Stock Exchange of India Limited dated May 29, 2026, regarding the utilization of proceeds from a preferential issue. The disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Finding

The company confirmed there is no deviation or variation in the use of proceeds raised through the preferential issue for the quarter ended March 31, 2026. This statement was reviewed and approved by the Audit Committee of the Company on May 29, 2026.

Fund Raising Details

• Date of Raising Funds: July 18, 2025
• Amount Raised: ₹339.10 lakh (₹3.391 crore)
• Monitoring Agency: Not Applicable
• Reporting Quarter: Ended March 31, 2026

Fund Utilization Breakdown

Funds were utilized exactly as originally allocated with no modifications:

1. Working Capital Requirement:

• Original Allocation: ₹52.10 lakh
• Amount Utilized: ₹52.10 lakh
• Deviation/Variation: None

2. Investment into New Projects or Opportunities or Ventures:

• Original Allocation: ₹132.46 lakh
• Amount Utilized: ₹2.00 lakh
• Deviation/Variation: None

3. Repayment of Unsecured Loans in Part to Promoter Director:

• Original Allocation: ₹88.31 lakh
• Amount Utilized: ₹88.31 lakh
• Deviation/Variation: None

4. General Corporate Purpose:

• Original Allocation: ₹66.23 lakh
• Amount Utilized: ₹34.32 lakh
• Deviation/Variation: None